TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,709,000 | -91.5% | 195,212 | -85.1% | 0.01% | -92.4% |
| Q3 2021 | $43,723,000 | -60.1% | 1,313,788 | -53.5% | 0.10% | -60.2% |
| Q2 2021 | $109,650,000 | -51.5% | 2,826,762 | -39.8% | 0.26% | -54.2% |
| Q1 2021 | $226,314,000 | -2.0% | 4,695,301 | +5.7% | 0.58% | -5.4% |
| Q4 2020 | $230,993,000 | +72.7% | 4,440,459 | -11.2% | 0.61% | +42.9% |
| Q3 2020 | $133,761,000 | +417.6% | 4,998,526 | +276.8% | 0.43% | +374.4% |
| Q2 2020 | $25,844,000 | +177.7% | 1,326,685 | +40.3% | 0.09% | +119.5% |
| Q1 2020 | $9,306,000 | +293.2% | 945,764 | +302.7% | 0.04% | +485.7% |
| Q3 2015 | $2,367,000 | -63.7% | 234,829 | -40.3% | 0.01% | -58.8% |
| Q2 2015 | $6,525,000 | – | 393,308 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |